- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 23 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 25 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.24: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: N.122, T.124, V.127
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain A: E.132, N.163
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain A: G.230, N.232
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain A: N.278, E.279, N.280
- Chain C: K.556
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain A: N.601, T.602
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain A: N.614
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain A: N.655
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain A: N.707, G.1129
- Chain B: D.794
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain B: N.122, T.124, V.127
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain B: E.132, N.163
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain B: G.230, N.232
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain A: K.556
- Chain B: N.278, E.279, N.280
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain B: N.601, T.602
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain B: N.614
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain B: N.655
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain C: N.122, T.124, V.127
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: E.132, N.163
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain B: E.463, R.464
- Chain C: G.230, N.232
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain B: K.556
- Chain C: N.278, E.279, N.280
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: N.601, T.602
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.614
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain C: N.655
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chi, X. et al., Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination. Signal Transduct Target Ther (2022)
- Release Date
- 2022-06-01
- Peptides
- Spike glycoprotein: ABC
heavy chain of ZWC6: DFH
heavy chain of ZWC6: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
IH
JE
LG
MI
N
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 23 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 25 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chi, X. et al., Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination. Signal Transduct Target Ther (2022)
- Release Date
- 2022-06-01
- Peptides
- Spike glycoprotein: ABC
heavy chain of ZWC6: DFH
heavy chain of ZWC6: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
IH
JE
LG
MI
N